Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight
Get Alerts CLDX Hot Sheet
Price: $39.48 --0%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Join SI Premium – FREE
Wells Fargo analyst Derek Archila upgraded Celldex Therapeutics (NASDAQ: CLDX) from Underweight to Equal Weight with a price target of $27.00.
For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.
Shares of Celldex Therapeutics closed at $25.78 yesterday.
You May Also Be Interested In
- Macquarie Upgrades Broadcom Limited (AVGO) to Outperform
- JPMorgan Upgrades Envista Holdings Corp. (NVST) to Overweight
- BNP Paribas Exane Upgrades Disco Corp. (6146:JP) (DSCSY) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share